Last reviewed · How we verify
varicella vaccine (VARIVAX)
varicella vaccine (VARIVAX) is a Biologic drug developed by The Hospital for Sick Children. It is currently in Phase 3 development for Prevention of chickenpox.
VARIVAX stimulates an immune response against the varicella-zoster virus.
VARIVAX stimulates an immune response against the varicella-zoster virus. Used for Prevention of chickenpox.
At a glance
| Generic name | varicella vaccine (VARIVAX) |
|---|---|
| Sponsor | The Hospital for Sick Children |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
VARIVAX contains a live attenuated varicella-zoster virus that is administered to induce immunity against chickenpox. This immune response is mediated by the activation of T-cells and the production of antibodies that target the virus.
Approved indications
- Prevention of chickenpox
Common side effects
- Fever
- Redness or swelling at the injection site
- Headache
- Fatigue
- Muscle pain
Key clinical trials
- Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial (PHASE3)
- Second Dose of Varicella Vaccine in Healthy Children (PHASE3)
- Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age (PHASE3)
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- varicella vaccine (VARIVAX) CI brief — competitive landscape report
- varicella vaccine (VARIVAX) updates RSS · CI watch RSS
- The Hospital for Sick Children portfolio CI
Frequently asked questions about varicella vaccine (VARIVAX)
What is varicella vaccine (VARIVAX)?
How does varicella vaccine (VARIVAX) work?
What is varicella vaccine (VARIVAX) used for?
Who makes varicella vaccine (VARIVAX)?
What development phase is varicella vaccine (VARIVAX) in?
What are the side effects of varicella vaccine (VARIVAX)?
Related
- Manufacturer: The Hospital for Sick Children — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of chickenpox
- Compare: varicella vaccine (VARIVAX) vs similar drugs
- Pricing: varicella vaccine (VARIVAX) cost, discount & access